Cogo Paola Elisa, Facco Maddalena, Simonato Manuela, Verlato Giovanna, Rondina Clementina, Baritussio Aldo, Toffolo Gianna Maria, Carnielli Virgilio Paolo
Departments of Pediatrics, University of Padua, Padua, Italy.
Pediatrics. 2009 Nov;124(5):e950-7. doi: 10.1542/peds.2009-0126. Epub 2009 Oct 12.
The goal was to study exogenous surfactant disaturated phosphatidylcholine (DSPC) kinetics in preterm infants with respiratory distress syndrome (RDS) who were treated with 100 or 200 mg/kg porcine surfactant.
Sixty-one preterm infants with RDS undergoing mechanical ventilation received, within 24 hours after birth, 100 mg/kg (N = 40) or 200 mg/kg (N = 21) porcine surfactant mixed with [U-(13)C]dipalmitoylphosphatidylcholine. Clinical and respiratory parameters were recorded, and DSPC half-life and pool size and endogenous DSPC synthesis rate were calculated.
Clinical characteristics and short-term outcomes did not differ between groups. In the 100 mg/kg group, 28 infants (70%) received a second dose after 25 +/- 11 hours and 9 (22.5%) a third dose after 41 +/- 11 hours; in the 200 mg/kg group, 6 infants (28.6%) received a second dose after 33 +/- 8 hours and 1 a third dose. The DSPC half-life was longer in the 200 mg/kg group (first dose: 32 +/- 19 vs 15 +/- 15 hours [P = .002]; second dose: 43 +/- 32 vs 21 +/- 13 hours [P = .025]). DSPC synthesis rates and pool sizes before the first and second doses did not differ between the groups. The 200 mg/kg group exhibited a greater reduction in the oxygenation index than did the 100 mg/kg group after the first (P = .009) and second (P = .018) doses.
Porcine surfactant given to preterm infants with RDS at a dose of 200 mg/kg resulted in a longer DSPC half-life, fewer retreatments, and better oxygenation index values.
研究接受100或200mg/kg猪肺表面活性物质治疗的呼吸窘迫综合征(RDS)早产儿中外源性肺表面活性物质二饱和磷脂酰胆碱(DSPC)的动力学。
61例接受机械通气的RDS早产儿在出生后24小时内接受100mg/kg(N = 40)或200mg/kg(N = 21)与[U-(13)C]二棕榈酰磷脂酰胆碱混合的猪肺表面活性物质。记录临床和呼吸参数,并计算DSPC半衰期、储备量和内源性DSPC合成率。
两组间临床特征和短期预后无差异。在100mg/kg组中,28例婴儿(70%)在25±11小时后接受第二剂,9例(22.5%)在41±11小时后接受第三剂;在200mg/kg组中,6例婴儿(28.6%)在33±8小时后接受第二剂,1例接受第三剂。200mg/kg组的DSPC半衰期更长(第一剂:32±19 vs 15±15小时[P = .002];第二剂:43±32 vs 21±13小时[P = .025])。两组在第一剂和第二剂之前的DSPC合成率和储备量无差异。在第一剂(P = .009)和第二剂(P = .018)之后,200mg/kg组的氧合指数降低幅度大于100mg/kg组。
给予RDS早产儿200mg/kg剂量的猪肺表面活性物质可导致DSPC半衰期延长、再次治疗次数减少且氧合指数值更佳。